OUR PROGRESS: THE INTERSECTION OF TECHNOLOGY AND MEDICINE
KYAN's PPM platform implicitly de-risks and accelerates the drug developmental process while optimizing for efficacy and safety. The results are better response rates from our medicines, and truly individualized treatment regimens.
KYAN currently has 3 novel drug formulations and 3 personalized regimens in pioneering clinical trials. An additional 2 novel formulations will advance to clinical trials within the next year.